TABLE 3.
Antibacterial activities of DS-2969b and reference compounds against MRSA clinical isolatesa
Compound | MIC (μg/ml) |
||
---|---|---|---|
Range | 50% | 90% | |
DS-2969b | 0.03–0.5 | 0.125 | 0.25 |
Linezolid | 0.5–2 | 1 | 2 |
Vancomycin | 0.03–2 | 1 | 2 |
Levofloxacin | 8–32 | 32 | 32 |
A total of 67 isolates were tested.